• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重新审视稳态树突状细胞亚群及其成熟阶段的耐受性的现有概念。

Revisiting Current Concepts on the Tolerogenicity of Steady-State Dendritic Cell Subsets and Their Maturation Stages.

机构信息

Institute for Virology and Immunobiology, University of Würzburg, 97070 Würzburg, Germany; and

Institute for Molecular Medicine, University Medical Center of the Johannes Gutenberg-University Mainz, 55122 Mainz, Germany.

出版信息

J Immunol. 2021 Apr 15;206(8):1681-1689. doi: 10.4049/jimmunol.2001315.

DOI:10.4049/jimmunol.2001315
PMID:33820829
Abstract

The original concept stated that immature dendritic cells (DC) act tolerogenically whereas mature DC behave strictly immunogenically. Meanwhile, it is also accepted that phenotypically mature stages of all conventional DC subsets can promote tolerance as steady-state migratory DC by transporting self-antigens to lymph nodes to exert unique functions on regulatory T cells. We propose that in vivo 1) there is little evidence for a tolerogenic function of immature DC during steady state such as CD4 T cell anergy induction, 2) all tolerance as steady-state migratory DC undergo common as well as subset-specific molecular changes, and 3) these changes differ by quantitative and qualitative markers from immunogenic DC, which allows one to clearly distinguish tolerogenic from immunogenic migratory DC.

摘要

最初的概念表明,未成熟树突状细胞(DC)表现出耐受性,而成熟的 DC 则表现出严格的免疫原性。同时,人们也接受这样一种观点,即所有常规 DC 亚群的表型成熟阶段都可以通过将自身抗原运送到淋巴结来作为稳态迁移 DC 发挥独特的功能,从而促进耐受性,作用于调节性 T 细胞。我们提出,在体内:1)稳态时未成熟 DC 几乎没有表现出耐受性的功能,例如 CD4 T 细胞失能诱导;2)所有作为稳态迁移 DC 的耐受作用都经历共同的以及亚群特异性的分子变化;3)这些变化与免疫原性 DC 的数量和质量标记物不同,这使得人们能够清楚地区分耐受性和免疫原性迁移 DC。

相似文献

1
Revisiting Current Concepts on the Tolerogenicity of Steady-State Dendritic Cell Subsets and Their Maturation Stages.重新审视稳态树突状细胞亚群及其成熟阶段的耐受性的现有概念。
J Immunol. 2021 Apr 15;206(8):1681-1689. doi: 10.4049/jimmunol.2001315.
2
Balancing between immunity and tolerance: an interplay between dendritic cells, regulatory T cells, and effector T cells.免疫与耐受之间的平衡:树突状细胞、调节性T细胞和效应T细胞之间的相互作用
J Leukoc Biol. 2007 Dec;82(6):1365-74. doi: 10.1189/jlb.0307166. Epub 2007 Aug 21.
3
Immature, but not inactive: the tolerogenic function of immature dendritic cells.未成熟但非无活性:未成熟树突状细胞的致耐受性功能
Immunol Cell Biol. 2002 Oct;80(5):477-83. doi: 10.1046/j.1440-1711.2002.01115.x.
4
Regulation of the tolerogenic function of steady-state DCs.稳态树突状细胞耐受性功能的调节。
Eur J Immunol. 2014 Apr;44(4):927-33. doi: 10.1002/eji.201343862. Epub 2014 Mar 20.
5
Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity?未成熟、半成熟和完全成熟的树突状细胞:哪些信号诱导耐受或免疫?
Trends Immunol. 2002 Sep;23(9):445-9. doi: 10.1016/s1471-4906(02)02281-0.
6
Dendritic cells: sentinels of immunity and tolerance.树突状细胞:免疫与耐受的哨兵
Int J Hematol. 2005 Apr;81(3):197-203. doi: 10.1532/IJH97.04165.
7
Dendritic cells and the immunity/tolerance decision.树突状细胞与免疫/耐受抉择
Med Hypotheses. 2005;64(1):112-3. doi: 10.1016/j.mehy.2004.02.061.
8
Dendritic cell-regulatory T-cell interactions control self-directed immunity.树突状细胞与调节性T细胞的相互作用控制自身导向免疫。
Immunol Cell Biol. 2007 Nov-Dec;85(8):575-81. doi: 10.1038/sj.icb.7100088. Epub 2007 Jun 26.
9
Modulation of tolerogenic dendritic cells and autoimmunity.耐受性树突状细胞与自身免疫的调节
Semin Cell Dev Biol. 2015 May;41:49-58. doi: 10.1016/j.semcdb.2014.04.020. Epub 2014 Apr 18.
10
Regulatory T cells and tolerogenic dendritic cells: from basic biology to clinical applications.调节性T细胞与耐受性树突状细胞:从基础生物学到临床应用
Immunol Lett. 2004 Jun 15;94(1-2):11-26. doi: 10.1016/j.imlet.2004.04.015.

引用本文的文献

1
N6.2 Phospholipids Induce T Cell Anergy upon Cognate Dendritic Cell Interactions.N6.2 磷脂在与同源树突状细胞相互作用时诱导T细胞无反应性。
Metabolites. 2025 Apr 22;15(5):284. doi: 10.3390/metabo15050284.
2
Allergens in Atopic Dermatitis.特应性皮炎中的变应原。
Clin Rev Allergy Immunol. 2025 Feb 10;68(1):11. doi: 10.1007/s12016-025-09024-7.
3
The Potential of Photodynamic Therapy Using Solid Lipid Nanoparticles with Aluminum Phthalocyanine Chloride as a Nanocarrier for Modulating Immunogenic Cell Death in Murine Melanoma In Vitro.
以氯化铝酞菁为纳米载体的固体脂质纳米粒用于体外调节小鼠黑色素瘤免疫原性细胞死亡的光动力疗法潜力
Pharmaceutics. 2024 Jul 14;16(7):941. doi: 10.3390/pharmaceutics16070941.
4
CD39 expression by regulatory T cells participates in CD8+ T cell suppression during experimental Trypanosoma cruzi infection.调节性 T 细胞表达 CD39 参与实验性克氏锥虫感染期间 CD8+ T 细胞的抑制。
PLoS Pathog. 2024 Apr 29;20(4):e1012191. doi: 10.1371/journal.ppat.1012191. eCollection 2024 Apr.
5
Therapeutic induction of antigen-specific immune tolerance.抗原特异性免疫耐受的治疗诱导。
Nat Rev Immunol. 2024 May;24(5):338-357. doi: 10.1038/s41577-023-00970-x. Epub 2023 Dec 12.
6
Recent advances in epicutaneous immunotherapy and potential applications in food allergy.经皮免疫疗法的最新进展及其在食物过敏中的潜在应用。
Front Allergy. 2023 Oct 27;4:1290003. doi: 10.3389/falgy.2023.1290003. eCollection 2023.
7
N6.2 phospholipids induce immature-like dendritic cells with a migratory-regulatory-like transcriptional signature.N6.2 磷脂诱导具有迁移调控样转录特征的幼稚样树突状细胞。
Gut Microbes. 2023 Dec;15(2):2252447. doi: 10.1080/19490976.2023.2252447.
8
NK cells reduce anergic T cell development in early-stage tumors by promoting myeloid cell maturation.自然杀伤细胞通过促进髓样细胞成熟来减少早期肿瘤中无反应性T细胞的发育。
Front Oncol. 2022 Dec 2;12:1058894. doi: 10.3389/fonc.2022.1058894. eCollection 2022.
9
Crosstalk between dendritic cells and regulatory T cells: Protective effect and therapeutic potential in multiple sclerosis.树突状细胞与调节性 T 细胞的相互作用:多发性硬化症中的保护作用和治疗潜力。
Front Immunol. 2022 Sep 13;13:970508. doi: 10.3389/fimmu.2022.970508. eCollection 2022.
10
Cutting-Edge Delivery Systems and Adjuvants in Tolerogenic Vaccines: A Review.耐受性疫苗中的前沿递送系统和佐剂:综述
Pharmaceutics. 2022 Aug 25;14(9):1782. doi: 10.3390/pharmaceutics14091782.